KaydedilenlerDerginizi ekleyin

Dergiler / İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi / 2018 / Cilt: 3 - Sayı: 3

Bazı Kronik Hastalıklarda Orta Zincirli Yağ Asitlerinin Kullanımı

Aylin BAYINDIR GÜMÜŞ
Hülya YARDIMCI
Sayfa
25–29
Yayın Tarihi
2018-10-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
🔖

Bu Makaleye Atıf Yap

GÜMÜŞ, A. B., YARDIMCI, H. (2018). Bazı Kronik Hastalıklarda Orta Zincirli Yağ Asitlerinin Kullanımı. İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi, Cilt: 3 - Sayı: 3, 25–29. https://ajindex.com/articles/772872

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Ahmad, Z.M.D. & Wilson, M.D.F. (2014). Familial chylomicronemia syndrome andresponse to medium-chain triglyceride therapy in an infant with novel mutations in GPIHBP1. Journal of Clinical Lipidology, 8, 635-639.
  2. Altınok, Y., Uçar, S., Kağnıcı, M, & Çoker, M. (2011, Nisan). Hipertrigliserimide MCT kullanım. Uluslararası Katılımlı XI. Metabolik Hastalıklar ve Beslenme Kongresi’nde sunulan bildiri. Çocuk Beslenme ve Metabolizma Derneği, İzmir.
  3. Asakura, L., Lottenberg, A.M., Neves, M.Q., Nunes, V.S., Rocha, J.C., et al. (2000). Dietary medium-chain triacylglycerol prevents the postprandial rise of plasma triacylglycerols but induces hypercholesterolemia in primary hypertriglyceridemic subjects. Am J Clin Nutr, 71(3), 701-705.
  4. Babayan, V.K. (1987). Medium chain triglycerides and structured lipids. Lipids, 22(6), 417-420.
  5. Chanez, M., Bois-Joyeux, B., Arnaud, M.J., & Peret, J. (1991). Metabolic effects in rats of a diet with a moderate level of medium-chain triglycerides. Journal of Nutrition, 121(5), 585-594.
  6. Freeman, J.M., Kosoff, E.H., & Hartman, A.L. (2007). The ketogenic diet: One decade later. Pediatrics, 119(3), 535-543. González-Domínguez, R. (2016). Medium-chain Fatty Acids as Biomarkers of Mitochondrial Dysfunction in Traumatic Brain Injury. EBioMedicine, 12, 8–9.
  7. Güzoğlu, N., Say, B., Uras, N., & Dilmen, U. (2014). Very Long-Chain Fatty Acid Dehydrogenase Deficiency in Newborn. Selçuk Tıp Dergisi, 30(3), 137-138.
  8. Han, J.R., Hamilton, J.A., Kirkland, J.L., Corkey, B.E., & Guo, W. (2003). Medium-chain oil reduces fat mass and downregulates expression of adipogenic genes in rats. Obesity Research, 11, 734–744.
  9. Hill, J.O., Peters, J.C., Swift, L.L., Yang, D., Sharp, T., Abumrad, N., et al. (1990). Changes in blood-lipids during 6 days of overfeeding with medium or long-chain triglycerides. Journal of Lipid Research, 31, 407–416.
  10. Kawai, K., Nakashima, M., Kojima, M., Yamashita, S., Takakura, S., Shimizu, M., et al. (2016). Ghrelin activation and neuropeptide Y elevation in response to medium chain triglyceride administration in anorexia nervosa patients. Clinical Nutrition ESPEN, 100-104.
  11. Kosoff, E. H. (2004). More fat and fewer seizures: Dietary therapies for epilepsy. The Lancet Neurology, 3, 415-420.
  12. Lambrechts, DA., De Kinderen, R.J., Vles, H.S., Louw, A.J., Aldenkamp, A.P., & Majoje, M.J. (2015). The MCT-ketogenic diet as a treatment option in refractory childhoodepilepsy: A prospective study with 2-year follow-up. Epilepsy & Behavior, 51, 261–266. L